Medical & Biological Laboratories Co., Ltd. (JASDAQ:4557) entered into business transfer contract to acquire histopathology examination businesses of Histo Science Laboratory Co., Ltd. for approximately ¥150 million in cash on July 4, 2013. Medical & Biological Laboratories will pay in cash in full upon the execution of the business transfer. During the year ended September 2012, the histopathology examination businesses had sales of ¥278.92 million, operating profit of ¥8.27 million, current profit of ¥2.65 million, net liabilities of ¥73.12 million and total assets of ¥269.2 million. The Board of Directors of Medical & Biological Laboratories resolved the transaction on July 4, 2013. The transaction is expected to close on July 19, 2013.

Medical & Biological Laboratories Co., Ltd. (JASDAQ:4557) cancelled the acquisition of histopathology examination businesses of Histo Science Laboratory Co., Ltd. on July 4, 2014.